Endometrial cancer
ICD-10 C54.1 · ICD-11 2C76

Treatment of Stage I–II Endometrial Cancer in Patients with Medical Comorbidities Precluding Standard Surgery

When stage I or II endometrial carcinoma is diagnosed in a patient whose medical comorbidities carry high operative and perioperative risks, standard surgical management may not be appropriate. Curative intent can still be pursued through carefully selected alternatives — the choice of approach depends on the individual patient's clinical situation.

Clinical Scenario

Stage I and II endometrial carcinoma in patients with medical comorbidities for whom standard surgery is precluded due to high operative and perioperative risks.

Treatment Overview (Partial)

Curative intent remains achievable in this setting. Depending on the patient's individual clinical profile, options include either a surgical approach or definitive radiotherapy. The structured protocol specifies which modality applies under which circumstances — that detail is available in full via the link below.

Complete selection criteria, modality details, and evidence grades are not shown here →

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1016/S1470-2045(25)00167-6

Vaginal hysterectomy with bilateral salpingo-oophorectomy, if feasible, can be considered as a curative option in patients unfit for the recommended standard surgical therapy (patients with medical comorbidities for whom standard surgery is precluded due to high operative and perioperative risks; IV, C).

Definitive curative radiotherapy is the treatment of choice in patients with a primary endometrial carcinoma diagnosis in whom standard surgery is contraindicated for medical reasons.

The combination of external beam radiotherapy plus intrauterine image-guided brachytherapy should be used for high-grade tumours or deep myometrial invasion or both (II, B).

For low-grade tumours without deep myometrial invasion, intrauterine image-guided brachytherapy alone can be considered as an alternative for the combination of external beam radiotherapy plus intrauterine image-guided brachytherapy (II, B).

View source ↗